The results suggest that B cells can drive the development of lung inflammation in chronic TB by enhancing the levels of protective interferon (IFN)-γ-producing CD4+ T cells while restricting the expression of the immunosuppressive, anti-inflammatory IL-10. The gene discussed is IFNG; the disease is tuberculosis.